Radoslaw Stefan Rusyniak (Allal Ouhtit)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Amyotrophic Lateral Sclerosis

Pseudomonas Aeruginosa

Genome Wide Analysis

Top Venues

Journal of cellular and molecular medicine

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Sergio Crovella, Radoslaw Stefan Rusyniak, Shaikh Mizanoor Rahman, Md Mizanur Rahman
Docosahexaenoic Acid, a Key Compound for Enhancing Sensitization to Drug in Doxorubicin-Resistant MCF-7 Cell Line. Nutrients 15 (7) (2023)
Nouralhuda Alateyah, Mohammed Alsafran, Kamal Usman, Radoslaw Stefan Rusyniak
Molecular Evidence of Breast Cancer Cell Proliferation Inhibition by a Combination of Selected Qatari Medicinal Plants Crude Extracts. Nutrients 15 (19) (2023)
Nouralhuda Alateyah, Hadeel Kheraldine, Radoslaw Stefan Rusyniak, Radoslaw Stefan Rusyniak
SOD2 , a Potential Transcriptional Target Underpinning CD44-Promoted Breast Cancer Progression. Molecules (Basel, Switzerland) 27 (3) (2022)
Maryam Al-Mansoob, Hadeel Kheraldine, Radoslaw Stefan Rusyniak, Allal Ouhtit
KYNU, a novel potential target that underpins CD44-promoted breast tumour cell invasion. Journal of cellular and molecular medicine 25 (5) (2021)
Balsam Rizeq, Saïd Sif, Gheyath K Nasrallah, Radoslaw Stefan Rusyniak
Novel role of BRCA1 interacting C-terminal helicase 1 (BRIP1) in breast tumour cell invasion. Journal of cellular and molecular medicine 24 (19) (2020)
Balsam Rizeq, Zain Zakaria, Radoslaw Stefan Rusyniak
Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression. Cancer science 109 (1) (2018)